World’s first dual-console robotic heart bypass surgery performed in India using SSI Mantra system
India has achieved a global milestone in robotic cardiac surgery after surgeons performed the world’s first dual-console, five-arm robotic beating-heart Totally Endoscopic Coronary Artery Bypass (TECAB) procedure at Medanta Hospital in Gurugram on November 18, 2026. Surgery was carried out using the indigenous SSI Mantra Surgical Robotic System and two surgeons operating at a time from different control consoles.
It was a complex procedure, which was led by Dr Nitin Kumar Rajput, Associate Director, Robotic and Minimally Invasive Cardiac Surgery, Medanta, and Dr Lalit Malik, Chief Cardiac Surgeon, Manipal Hospital, Jaipur, and supervised by Dr Sudhir Srivastava, Founder, Chairman and CEO, SS Innovations International. The procedure highlights the advanced medical technological capabilities of India’s cardiac surgery.
According to the hospital, both surgeons operated in synchronisation using all five robotic arms of the SSI Mantra system. A heart stabilisation system was used to maintain stability of the target area while the heart was beating.
TECAB is a newer technique that is used for coronary artery bypass surgery without opening the chest wall. This technique provides surgeons with the opportunity to use robotic instruments in surgery, whereas conventional bypass surgery uses a large incision made through the breastbone. The beating-heart method also gives the surgeon the option to not use a heart-lung machine during the surgery.
This dual console setup enabled both surgeons to operate the robot and coordinate their movements. It also provides some hands-on learning and gives a second surgeon experience in complex procedures with the robotic system.
Patient recovery highlights the potential of minimally invasive surgery
The progress of the patient in recovery in 15 days was encouraging, Medanta said. In fact, the hospital pointed out, one of the most significant advances in minimally invasive cardiac care is the procedure, but the long-term clinical effects will be significant for determining the benefits.
It is a testament to the focus of surgical innovation and advanced technology at Medanta, said Dr Naresh Trehan, Chairman & Managing Director of Medanta. He also said that the complex cardiac procedures may be performed in a less invasive way for the patients with robotic surgery.
Dr Nitin Kumar Rajput said the procedure required precision, coordination and close collaboration between the two surgeons. He noted that the patient’s recovery following surgery was encouraging.
SSI Mantra highlights India’s growing surgical robotics capabilities
Commenting on the milestone, Dr Sudhir Srivastava said the procedure demonstrated the capabilities of the SSI Mantra system in advanced minimally invasive cardiac surgery. The success is in line with the company’s vision, ‘Make in India, for the World’, and the objective of making robotic surgery more accessible and affordable, he said.
Dr Lalit Malik also commented that the dual console concept was a significant stride towards robotic cardiac surgery, and coordinated control, along with the 5-arm configuration, met the surgical demands of the procedure.
The SSI Mantra Surgical Robotic System, developed by SS Innovations International, India, is a surgical robotic system designed for complex surgeries. The new success has brought India’s homegrown surgical robotics technology to the fore and its promise to increase access to cutting-edge cardiac care in the country.